Depreciation of Rapport Therapeutics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Rapport Therapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Rapport Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $200,000, unchanged year-over-year.
  • Rapport Therapeutics, Inc. Depreciation for the twelve months ending 31 Mar 2025 was $800,000.
  • Rapport Therapeutics, Inc. annual Depreciation for 2025 was $1,000,000, a 25% increase from 2024.
  • Rapport Therapeutics, Inc. annual Depreciation for 2024 was $800,000, a 700% increase from 2023.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Rapport Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,000,000 +$200,000 +25% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $800,000 +$700,000 +700% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $100,000 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY

Rapport Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $800,000 $200,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $800,000 $200,000 01 Oct 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 $200,000 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $200,000 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $200,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.